Condition
Resectable clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Resectable clinical trials that are recruiting, at sites in 2 countries (most in Netherlands (1), France (1)). By phase: Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab vs upfront surgery for cancers of the bile ducts
This trial tests whether giving chemotherapy with pembrolizumab before surgery helps people with resectable or borderline resectable extrahepatic cholangiocarcinoma see if they have better outcomes than going straight to surgery.
-
Intensified pre-surgery chemotherapy for adults with high-risk resectable soft-tissue sarcoma
This study will try giving three extra cycles of doxorubicin-based chemotherapy before surgery to adults with resectable, high‑risk CINSARC soft-tissue sarcoma to see if it lowers the chance of the cancer spreading.
Related topics
Quick answers
How many Resectable clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Netherlands (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.